Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

France

ICO - Site Paul Papin, Angers

Institut Bergonie, Bordeaux

Institut de cancérologie de Montpellier, Montpellier

Centre Antoine Lacassagne, Nice

Institut Curie - Site de Paris, Paris

Hopital Saint Joseph, Paris

Institut de Cancérologie de l'Ouest, Saint-Herblain

IUCT-O, Toulouse